OBIO News, Ontario Industry Updates Arsheen Kaur 12/10/24 OBIO News, Ontario Industry Updates Arsheen Kaur 12/10/24 Mutuo Acquired by HEALWELL to Build Next Generation of AI-powered Physician Co-Pilots Read More OBIO News, Ontario Industry Updates Arsheen Kaur 12/10/24 OBIO News, Ontario Industry Updates Arsheen Kaur 12/10/24 KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into the Clinic Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 Roche Canada Announces New Informatics Jobs in Ontario’s Life Sciences Sector Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 New X-ray Imaging Technique Improves Diagnostic Confidence for Early Identification of Heart Disease Risk Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 AmacaThera Announces Successful Phase 1 Results of First-in-Human Study with AMT-143 Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/12/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/12/24 Zucara Therapeutics Announces Strategic Investment from Sanofi as Part of US$20 M Series B Financing Read More OBIO News, Ontario Industry Updates Arsheen Kaur 11/12/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/12/24 Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos Read More Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Federal Government Launches Health Emergency Readiness Canada to Strengthen Preparedness for Future Health Emergencies Read More Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie Read More Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 IRegained Secures a U.S. Distribution Deal for Their Stroke Rehabilitation Device Read More Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Able Innovations Opens New Simulation Lab Read More Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Rehabtronics to Join PressureSmart Consortium for Advancing Pressure Injury Prevention Using AI Read More Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Radiant Bio Closes $35 Million Series A Financing Read More Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Study Demonstrates Reveal 35C’s Impact in the ICU Read More Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 HDAX Therapeutics Announces First Closing of Oversubscribed US $3.2 Million Seed Financing Read More Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Canadian Medical Technology Consortium Collaborates on State-of-the-Art Postoperative Patient Management Platform, Led by FluidAI Read More Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Feldan Therapeutics Completes a US$ 21 Million Series B Financing Read More Ontario Industry Updates, OBIO News Arsheen Kaur 9/3/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/3/24 Novartis celebrates Canada-wide implementation of newborn screening for spinal muscular atrophy Read More Ontario Industry Updates, OBIO News Arsheen Kaur 8/20/24 Ontario Industry Updates, OBIO News Arsheen Kaur 8/20/24 Fibra Raises $1.25M in Pre-Seed Round to Advance Fertility Tracking Underwear Read More Ontario Industry Updates, OBIO News Arsheen Kaur 8/20/24 Ontario Industry Updates, OBIO News Arsheen Kaur 8/20/24 Satellos Receives Rare Pediatric Disease Designation from the U.S. FDA for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy Read More Newer Posts Older Posts
OBIO News, Ontario Industry Updates Arsheen Kaur 12/10/24 OBIO News, Ontario Industry Updates Arsheen Kaur 12/10/24 Mutuo Acquired by HEALWELL to Build Next Generation of AI-powered Physician Co-Pilots Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 12/10/24 OBIO News, Ontario Industry Updates Arsheen Kaur 12/10/24 KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into the Clinic Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 Roche Canada Announces New Informatics Jobs in Ontario’s Life Sciences Sector Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 New X-ray Imaging Technique Improves Diagnostic Confidence for Early Identification of Heart Disease Risk Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/26/24 AmacaThera Announces Successful Phase 1 Results of First-in-Human Study with AMT-143 Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/12/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/12/24 Zucara Therapeutics Announces Strategic Investment from Sanofi as Part of US$20 M Series B Financing Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/12/24 OBIO News, Ontario Industry Updates Arsheen Kaur 11/12/24 Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Federal Government Launches Health Emergency Readiness Canada to Strengthen Preparedness for Future Health Emergencies Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 IRegained Secures a U.S. Distribution Deal for Their Stroke Rehabilitation Device Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Ontario Industry Updates, OBIO News Arsheen Kaur 10/1/24 Able Innovations Opens New Simulation Lab Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Rehabtronics to Join PressureSmart Consortium for Advancing Pressure Injury Prevention Using AI Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Radiant Bio Closes $35 Million Series A Financing Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Study Demonstrates Reveal 35C’s Impact in the ICU Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 HDAX Therapeutics Announces First Closing of Oversubscribed US $3.2 Million Seed Financing Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Canadian Medical Technology Consortium Collaborates on State-of-the-Art Postoperative Patient Management Platform, Led by FluidAI Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/18/24 Feldan Therapeutics Completes a US$ 21 Million Series B Financing Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 9/3/24 Ontario Industry Updates, OBIO News Arsheen Kaur 9/3/24 Novartis celebrates Canada-wide implementation of newborn screening for spinal muscular atrophy Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 8/20/24 Ontario Industry Updates, OBIO News Arsheen Kaur 8/20/24 Fibra Raises $1.25M in Pre-Seed Round to Advance Fertility Tracking Underwear Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 8/20/24 Ontario Industry Updates, OBIO News Arsheen Kaur 8/20/24 Satellos Receives Rare Pediatric Disease Designation from the U.S. FDA for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy Read More
